Dimaril (glimepiride) tablets 3 mg. №60

$24.00

Manufacturer: Ukraine

Purpose: Stimulates insulin release to control blood sugar in type 2 diabetes.

SKU: MED57848 Category:

Description

Dimaril (glimepiride) tablets 3 mg. №60

Ingredients

Active ingredient: Glimepiride 3 mg.
Other ingredients: Lactose monohydrate, microcrystalline cellulose, povidone, and magnesium stearate.

Dosage

Recommended dosage: The usual starting dose is 1 to 2 mg once daily with breakfast or the first main meal. Dosage adjustments should be made based on blood glucose levels.

Indications

Dimaril tablets are indicated for the treatment of type 2 diabetes mellitus when diet, exercise, and weight reduction alone are not sufficient.

Contraindications

Do not use Dimaril tablets in patients with a history of hypersensitivity to glimepiride or other sulfonylureas.

Directions

Take Dimaril tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water.

Scientific Evidence

Glimepiride, the active ingredient in Dimaril tablets, is a sulfonylurea that works by increasing insulin release from the pancreas. Studies have shown that glimepiride effectively lowers blood glucose levels in patients with type 2 diabetes. Research published in the Journal of Diabetes Investigation demonstrated the efficacy of glimepiride in improving glycemic control and reducing HbA1c levels.

Additional Information

It is important to monitor blood glucose levels regularly while taking Dimaril tablets to ensure optimal control of diabetes. Inform your healthcare provider about all medications you are taking to prevent potential drug interactions.

Pharmacological Effects: Glimepiride stimulates the release of insulin from pancreatic beta cells, thereby lowering blood glucose levels. It also improves insulin sensitivity in peripheral tissues.

Clinical Trials: Clinical trials have shown that glimepiride is as effective as other sulfonylureas in controlling blood sugar levels in patients with type 2 diabetes. A study published in Diabetes Care compared the efficacy and safety of glimepiride with glibenclamide and found similar outcomes in terms of glycemic control.